FDA Panel Backs Two Peptides For Compounding, Rejects One

MONDAY, July 27, 2026— A federal advisory panel has recommended allowing compounding pharmacies to make two more unproven peptides while voting to reject a third.The U.S. Food and Drug Administration (FDA) committee voted Friday to add epitalon...